S&P 500   3,577.59 (+0.56%)
DOW   29,591.27 (+1.12%)
QQQ   290.39 (+0.00%)
AAPL   113.85 (-2.97%)
MSFT   210.11 (-0.13%)
FB   268.43 (-0.47%)
GOOGL   1,727.56 (-0.51%)
AMZN   3,098.39 (-0.03%)
TSLA   521.85 (+6.58%)
NVDA   525.60 (+0.40%)
BABA   270.11 (-0.23%)
CGC   24.72 (+4.22%)
GE   10.07 (+3.18%)
MU   64.18 (+4.53%)
AMD   85.31 (+0.79%)
T   28.62 (+1.06%)
NIO   55.38 (+12.45%)
F   8.86 (+1.37%)
ACB   7.18 (+0.70%)
GILD   59.89 (-0.37%)
NFLX   476.62 (-2.38%)
BA   211.53 (+5.97%)
DIS   145.98 (+3.48%)
S&P 500   3,577.59 (+0.56%)
DOW   29,591.27 (+1.12%)
QQQ   290.39 (+0.00%)
AAPL   113.85 (-2.97%)
MSFT   210.11 (-0.13%)
FB   268.43 (-0.47%)
GOOGL   1,727.56 (-0.51%)
AMZN   3,098.39 (-0.03%)
TSLA   521.85 (+6.58%)
NVDA   525.60 (+0.40%)
BABA   270.11 (-0.23%)
CGC   24.72 (+4.22%)
GE   10.07 (+3.18%)
MU   64.18 (+4.53%)
AMD   85.31 (+0.79%)
T   28.62 (+1.06%)
NIO   55.38 (+12.45%)
F   8.86 (+1.37%)
ACB   7.18 (+0.70%)
GILD   59.89 (-0.37%)
NFLX   476.62 (-2.38%)
BA   211.53 (+5.97%)
DIS   145.98 (+3.48%)
S&P 500   3,577.59 (+0.56%)
DOW   29,591.27 (+1.12%)
QQQ   290.39 (+0.00%)
AAPL   113.85 (-2.97%)
MSFT   210.11 (-0.13%)
FB   268.43 (-0.47%)
GOOGL   1,727.56 (-0.51%)
AMZN   3,098.39 (-0.03%)
TSLA   521.85 (+6.58%)
NVDA   525.60 (+0.40%)
BABA   270.11 (-0.23%)
CGC   24.72 (+4.22%)
GE   10.07 (+3.18%)
MU   64.18 (+4.53%)
AMD   85.31 (+0.79%)
T   28.62 (+1.06%)
NIO   55.38 (+12.45%)
F   8.86 (+1.37%)
ACB   7.18 (+0.70%)
GILD   59.89 (-0.37%)
NFLX   476.62 (-2.38%)
BA   211.53 (+5.97%)
DIS   145.98 (+3.48%)
S&P 500   3,577.59 (+0.56%)
DOW   29,591.27 (+1.12%)
QQQ   290.39 (+0.00%)
AAPL   113.85 (-2.97%)
MSFT   210.11 (-0.13%)
FB   268.43 (-0.47%)
GOOGL   1,727.56 (-0.51%)
AMZN   3,098.39 (-0.03%)
TSLA   521.85 (+6.58%)
NVDA   525.60 (+0.40%)
BABA   270.11 (-0.23%)
CGC   24.72 (+4.22%)
GE   10.07 (+3.18%)
MU   64.18 (+4.53%)
AMD   85.31 (+0.79%)
T   28.62 (+1.06%)
NIO   55.38 (+12.45%)
F   8.86 (+1.37%)
ACB   7.18 (+0.70%)
GILD   59.89 (-0.37%)
NFLX   476.62 (-2.38%)
BA   211.53 (+5.97%)
DIS   145.98 (+3.48%)
Log in
LON:AVO

Advanced Oncotherapy plc (AVO.L) Share Forecast, Price & News

GBX 30.49
+0.49 (+1.63 %)
(As of 11/23/2020 03:41 PM ET)
Add
Compare
Today's Range
29.40
Now: GBX 30.49
31
50-Day Range
28
MA: GBX 33.12
38.52
52-Week Range
20
Now: GBX 30.49
43
Volume168,966 shs
Average Volume147,900 shs
Market Capitalization£101.67 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, selling, and maintaining proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.
Read More
Advanced Oncotherapy plc (AVO.L) logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.44 out of 5 stars


Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-20-36178728
Employees129

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Cash FlowGBX 1.93 per share
Book ValueGBX 17.60 per share

Profitability

Miscellaneous

Market Cap£101.67 million
Next Earnings DateN/A
OptionableNot Optionable
GBX 30.49
+0.49 (+1.63 %)
(As of 11/23/2020 03:41 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AVO News and Ratings via Email

Sign-up to receive the latest news and ratings for AVO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Advanced Oncotherapy plc (AVO.L) (LON:AVO) Frequently Asked Questions

How has Advanced Oncotherapy plc (AVO.L)'s stock been impacted by COVID-19?

Advanced Oncotherapy plc (AVO.L)'s stock was trading at GBX 32.50 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, AVO shares have decreased by 6.2% and is now trading at GBX 30.49.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Advanced Oncotherapy plc (AVO.L)?

Wall Street analysts have given Advanced Oncotherapy plc (AVO.L) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Advanced Oncotherapy plc (AVO.L) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Advanced Oncotherapy plc (AVO.L)'s earnings last quarter?

Advanced Oncotherapy plc (AVO.L) (LON:AVO) posted its quarterly earnings data on Monday, June, 29th. The company reported ($9.83) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($8.90) by $0.93.
View Advanced Oncotherapy plc (AVO.L)'s earnings history
.

Who are some of Advanced Oncotherapy plc (AVO.L)'s key competitors?

What other stocks do shareholders of Advanced Oncotherapy plc (AVO.L) own?

Who are Advanced Oncotherapy plc (AVO.L)'s key executives?

Advanced Oncotherapy plc (AVO.L)'s management team includes the following people:
  • Dr. Michael Jeffrey Sinclair, Exec. Chairman (Age 77, Pay $554.93k)
  • Mr. Nicolas Serandour, CEO & Exec. Director
  • Prof. Stephen Myers, Exec. Director (Age 73, Pay $255.69k)
  • Mr. Ed Lee, COO & Pres of Europe
  • Mr. Graham Pughe, Sr. Vice-Pres of Accounting & IT
  • Dr. Manuel Gallas, Director of Technical & Engineering
  • Mr. David Navas, VP of Investor and PR
  • Ms. Bridget Biggar, Director of HR
  • Ms. Donatella Ungaro, Managing Director of ADAM
  • Ms. Marina Giunta, Head of Physics Group

What is Advanced Oncotherapy plc (AVO.L)'s stock symbol?

Advanced Oncotherapy plc (AVO.L) trades on the London Stock Exchange (LON) under the ticker symbol "AVO."

How do I buy shares of Advanced Oncotherapy plc (AVO.L)?

Shares of AVO and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Advanced Oncotherapy plc (AVO.L)'s stock price today?

One share of AVO stock can currently be purchased for approximately GBX 30.49.

How big of a company is Advanced Oncotherapy plc (AVO.L)?

Advanced Oncotherapy plc (AVO.L) has a market capitalization of £101.67 million. Advanced Oncotherapy plc (AVO.L) employs 129 workers across the globe.

What is Advanced Oncotherapy plc (AVO.L)'s official website?

The official website for Advanced Oncotherapy plc (AVO.L) is www.advancedoncotherapy.com.

How can I contact Advanced Oncotherapy plc (AVO.L)?

Advanced Oncotherapy plc (AVO.L)'s mailing address is Third Fl Clearwater HSE, 4-7 Manchester Street, LONDON, W1U 3AE, United Kingdom. The company can be reached via phone at +44-20-36178728.

This page was last updated on 11/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.